EDIT:NASDAQ
Editas Medicine Inc
US$ 1.78
arrow_upward
+0.85%(+0.015) Siku 1
19 Nov, 13:58:39 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EDIT...
Fungua
US$ 1.80
Juu
US$ 1.83
Chini
US$ 1.73
Mtaji wa soko
275.50M
Wastani wa kiasi cha mauzo
2.38M
Kiasi cha mauzo ya hisa
1.07M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Fungua
US$ 1.80
Juu
US$ 1.83
Chini
US$ 1.73
Mtaji wa soko
275.50M
Wastani wa kiasi cha mauzo
2.38M
Kiasi cha mauzo ya hisa
1.07M
Juu kwa wiki 52
US$ 3.94
Chini kwa wiki 52
US$ 1.66
EPS
-US$ 0.62
Beta
2.09
Hisa za wawekezaji
154.34M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Motley Fool
·
dakika 13 zilizopita
The S&P 500 Is Flashing Warning Signs. Here's Why Long-Term Investors Should Stay the Course.
The Harvard Law School Forum on Corporate Governance
·
saa 6 zilizopita
Board Practices and Composition in the Russell 3000 and S&P 500
Benzinga
·
saa 1 iliyopita
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
24/7 Wall St.
·
saa 1 iliyopita
S&P 500 Drops Nearly 1% at Midday While the Dow Slides 1.5%
Wasifu
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Kuhusu Editas Medicine Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
LilianzishwaNov 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutieditasmedicine.com